Assignment of Assignor's Interest

Recorded: 2006-01-16 Pages: 5

Assignor

GRYPHON THERAPEUTICS, INC.

Executed: 2005-12-21

Assignee

AMYLIN PHARMACEUTICALS, INC.

9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121

Covered Properties (5)

Solid Phase Native Chemical Ligation of Unprotected or N-Terminal Cysteine Protected Peptides in Aqueous Solution

Patent: 6,326,468 →

Application: 09/097,094 →

Solid Phase Native Chemical Ligation of Unprotected or N-Terminal Cysteine Protected Peptides in Aqueous Solution

Patent: 7,094,871 →

Application: 09/987,655 →

Publication: US 2002/0132975

Solid Phase Native Chemical Ligation of Unprotected or N-Terminal Cysteine Protected Peptides in Aqueous Solution

Patent: 7,030,217 →

Application: 09/987,675 →

Publication: US 2002/0169282

Solid phase native chemical ligation of unprotected or N-terminal Cysteine protected peptides in aqueous solution

Application: 11/119,831 →

Publication: US 2005/0209440

Solid Phase Sequential Chemical Ligation of Unprotected Peptides in Aqueous Solution

Application: 60/049,553 →

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.